Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 4-Week, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone in the Prevention of Risperidone-Induced Weight Gain in Healthy Male Volunteers

Next Previous
Trial Profile

A 4-Week, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone in the Prevention of Risperidone-Induced Weight Gain in Healthy Male Volunteers

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 09 Feb 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Mifepristone (Primary) ; Risperidone
  • Indications Schizophrenia; Weight gain
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Corcept Therapeutics

Most Recent Events

  • 28 Jun 2009 Results presented at the 9th World Congress of Biological Psychiatry 2009.
  • 05 Jun 2009 The primary endpoint 'Bodyweight' has been Met according to the result published as an abstract in the proceedings of the 69th Annual Scientific Sessions of the American Diabetes Association.
  • 02 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top